1,597 hedge funds and large institutions have $95.7B invested in Amgen in 2017 Q1 according to their latest regulatory filings, with 151 funds opening new positions, 680 increasing their positions, 576 reducing their positions, and 71 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding in top 10

Funds holding in top 10:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more capital invested

Capital invested by funds: $ → $

4% more funds holding

Funds holding: 1,5381,597 (+59)

1.05% more ownership

Funds ownership: 78.09%79.15% (+1.1%)

33% less call options, than puts

Call options by funds: $1.14B | Put options by funds: $1.7B

Holders
1,597
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
79
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1.14B
Puts
$1.7B
Net Calls
Net Calls Change

Top Buyers

1 +$7.72B
2 +$2.26B
3 +$592M
4
Barclays
Barclays
United Kingdom
+$248M
5
Goldman Sachs
Goldman Sachs
New York
+$164M

Top Sellers

1 -$1.36B
2 -$392M
3 -$151M
4
Primecap Management
Primecap Management
California
-$148M
5
O
OrbiMed
New York
-$148M
Name Holding Trade Value Shares
Change
Change in
Stake
1326
$355K
1327
$353K
1328
$350K
1329
$347K
1330
$346K
1331
$344K
1332
$344K
1333
$343K
1334
$341K
1335
$338K
1336
$338K
1337
$337K
1338
$337K
1339
$332K
1340
$331K
1341
$328K
1342
$328K
1343
$328K
1344
$328K
1345
$328K
1346
$328K
1347
$328K
1348
$326K
1349
$323K
1350
$323K